WE INVEST IN PEOPLE.
VENTURE CAPITAL FOR HIGH-TECH FOUNDERS.
MADE IN GERMANY.

Seed investor for high-tech start-ups

HTGF is a venture capital investor for innovative technologies and business models. We successfully support the best founders whose ideas can revolutionise entire industries and improve people’s lives – from seed to exit.

As a seed investor, we have already financed more than 650 start-ups in the industrial tech, digital tech, life sciences and chemicals sectors. We have overseen more than 140 exits, including IPOs. When founding your company together with us, you benefit from an experienced partner at your side.
Further information for founders

We are a public–private partnership that works closely and successfully with companies from a wide range of industries. Our more than 30 fund investors include medium-sized companies, family businesses and corporations. We provide them with access to innovative start-ups and technologies insights into deal flows and connections to our global network.
Further information for fund investors

More than
140
Exits & IPOs
More than
650
Investments
 
895 M €
Mio. under Management
 
35
Fund investors

Our portfolio

Our investment companies are the heart of HTGF. We are proud of each and every one of them. Our investment managers have a direct line to the founders and are on hand with support and the entire HTGF network.

All our investments
HTGF shares its experience with us in matters of reporting, for example. That helps enormously when it comes to optimizing processes on the one hand and remaining transparent on the other. However, the investor never intervenes more deeply than necessary, so that our start-up momentum is maintained.
Dipl. Ing. Miriam Haerst Co-founder and managing partner
HTGF has developed a very rational and scientific approach to addressing problems in start-ups. I like that. The experience and the breadth of the portfolio make that possible.
Pierre Baqué Co-Founder / CEO – Neutral Concept Ltd.
Participating in HTGF’s network as a start-up cannot be overstated. We met our first customer at an HTGF event, even though we weren’t even in the portfolio at the time.
Philipp Bürling Founder Numaferm GmbH
HTGF has supported us unconditionally for many years. On the journey of a startup, many things develop differently than expected. We entrepreneurs therefore need a partner who supports us with advice and peace of mind to get up anew each time and make things better.
Philipp Roesch-Schlanderer Founder and managing director eGym
HTGF was the first investor who understood our idea and vision and invested pre-product.
Julia Bösch Founder and managing director OUTFITTERY
We really enjoy being at the HTPC every year. This is where we meet corporate champions from large industrial companies who pass us on to the relevant contacts. That’s worth its weight in gold for our business development.
Dr. Tim Pohlmann Founder and managing director IPlytics GmbH
At Family Day, we found a strong investor for our follow-on financing.
Felix Brand Founder and managing director CardioSecur

Insights

Press
14. October 2021

BASF Venture Capital and Amathaon Capital Acquire Minority Stake in Bioinformatics Company Computomics

Computomics AI recommends crosses adapted to future climatic conditionsPlant breeders can significantly accelerate market launch of new varietiesInvestment promotes innovative solutions for more sustainable agriculture Tübingen, Munich and Ludwigshafen, October 14, 2021 – BASF Venture Capital GmbH (BVC), the corporate venture company of BASF Group, and Amathaon Capital, a venture capital company specializing in AgTech, are investing in the Tübingen-based bioinformatics company Compu
 
Press
14. October 2021

Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million

Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy candidates toward clinical proof-of-concept Düsseldorf, Germany, October 14, 2021 – Abalos Therapeutics announced today an extension to its Series A funding round bringing the total raised in this round to EUR 43 million (USD 50 million). The extension was led by Seventure Partners with support from Coparion, Ventura BioMed Investors and Hx Bio Ventures as well as contributions from exist
 
Blog
5. October 2021

Life Science Pitch Day: Real entrepreneurs, real innovation, real added value

It was a special moment when CureVac founder Ingmar Hoerr shared his business story at the Life Science Pitch Day. More than 30 start-ups, investors, and scientists took part in the event at the end of September, which was organised by High-Tech Gründerfonds (HTGF) together with partners Bayer, Boehringer Ingelheim and the Innovation and Start-Up Center Biotechnology (IZB). We spoke to the event organisers at HTGF: Dr. Caroline Fichtner and Dr. Martin Pfister, both HTGF Principals, touched
 

Our Exits

Finding a promising Start-up is our expertise, then leading it to a successful exit is our job. We are very proud of every sale, in most cases to grow further with even more energy.

All exits

We work as a team. Our investment managers contribute a great deal of experience and expertise. They are not only financing experts, but many of them have also founded their own companies or bring years of industry experience or specialized scientific know-how with them.

Our start-ups become part of the #HTGFFamily, one of the strongest networks in the high-tech venture sector, where we use our expertise to actively support growth, customer acquisition, hiring, co-investment and follow-up financing.

Become Part of the HTGF Family

Are you the founder of a high-tech start-up? Does your company match our industry focus and meet our investment criteria? Then we look forward to getting to know you and your company! Send us your pitch deck – we’ll be in touch.

Sector focus?

We invest in start-ups in the fields of industrial technology, digital tech, life sciences and chemistry.

Investment criteria?

Your start-up is less than three years old and its headquarters are in Germany. Start-ups from abroad need a clear connection to Germany.

Financing?

We invest flexibly according to the needs of the start-up.

Investment volume?

In the seed round up to 1 million euros. In total we can invest up to 3 million euros in a start-up.

Added Value?

We are sparring partners in all questions regarding the development of start-ups and will open doors for you.